Prophylactic high‐dose granulocyte transfusions following allogeneic haematopoietic stem cell transplantation
Optimized high-dose PGTx resulted in a measurable ANC increase and was well tolerated. Although efficacy and safety remain to be established, we highlight the ability to produce and implement optimized high-dose PGTx for high-risk patients undergoing HSCT.
Authors
- Darrell J. Triulzi
- Randy M. Windreich
- Paul Szabolcs (ORCID: https://orcid.org/0000-0001-8561-4076)
- Yannis Hadjiyannis (ORCID: https://orcid.org/0000-0001-6723-4299)
- Joseph E. Kiss (ORCID: https://orcid.org/0000-0001-6767-1528)
- Alesia Kaplan (ORCID: https://orcid.org/0000-0002-8746-0549)
- Christopher C. Marino
- Robert Bubar (ORCID: https://orcid.org/0000-0003-0121-4636)
Institutions
- Vitalant (US)
- UPMC Hillman Cancer Center (US)
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- Vox Sanguinis
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1111/vox.70044
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00